IP Verse

Composite Capsule Preparation Containing Tadalafil And Tamsulosin And Having Improved Stability And Elution Rate - EP3421034

The patent EP3421034 was granted to Hanmi Pharm on Nov 16, 2022. The application was originally filed on Mar 31, 2017 under application number EP17775932A. The patent is currently recorded with a legal status of "Revoked".

EP3421034

HANMI PHARM
Application Number
EP17775932A
Filing Date
Mar 31, 2017
Status
Revoked
Jan 24, 2025
Grant Date
Nov 16, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKAug 16, 2023ELKINGTON AND FIFEADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTKR20080007252
INTERNATIONAL-SEARCH-REPORTKR20130039797
INTERNATIONAL-SEARCH-REPORTKR20150002550
INTERNATIONAL-SEARCH-REPORTKR20150056444
INTERNATIONAL-SEARCH-REPORTKR20160002412
OPPOSITIONKR20160002411
OPPOSITIONUS7018658
OPPOSITIONWO2014209087
SEARCHEP3150201
SEARCHKR20160002411
SEARCHWO2014209087

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SOLODYN safely and effectively. See full prescribing information for SOLODYN®", Solodyn® prescribing leaflet, (20100801), pages 1 - 8, XP093111250
OPPOSITION- Anonymous, "Polyethylene Glycol", Anonymous, Raymond C Rowe, Paul J Sheskey , Marian E Quinn, Handbook of Pharmaceutical Excipients Sixth edition, Pharmaceutical Press, (20090101), pages 517 - 517, XP093111234
OPPOSITION- Anonymous, "Polyvinyl Alcohol", Anonymous, Raymond C Rowe, Paul J Sheskey , Marian E Quinn, Handbook of Pharmaceutical Excipients Sixth edition, Pharmaceutical Press, (20090101), pages 564 - 564, XP093111238
OPPOSITION- Anonymous, "Triacetin", Anonymous, Raymond C Rowe, Paul J Sheskey , Marian E Quinn, Handbook of Pharmaceutical Excipients Sixth edition, Pharmaceutical Press, (20090101), pages 748 - 748, XP093111240
OPPOSITION- Rajabi-Siahboomi Ali R, Marina Levina, Sampada B. Upadhye, Jason Teckoe, "Excipient Selection in Oral Solid Dosage Formulations Containing Moisture Sensitive Drugs", Rajabi-Siahboomi Ali R, Marina Levina, Sampada B. Upadhye, Jason Teckoe, Narang Ajit S, Boddu Sai H S., Excipient Applications in Formulation Design and Drug Delivery, Switzerland, Springer International Publishing, (20150101), pages 385 - 421, ISBN 978-3-319-20206-8, XP093111241
OPPOSITION- Anneleen Burggraeve, Tinne Monteyne, Chris Vervaet, Jean Paul Remon, Thomas De Beer, "Process analytical tools for monitoring, understanding, and control of pharmaceutical fluidized bed granulation: A review", European journal of pharmaceutics and biopharmaceutics, NL , (20130101), vol. 83, no. 1, doi:10.1016/j.ejpb.2012.09.008, ISSN 0939-6411, pages 2 - 15, XP055289832

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents